We are monitoring the impact of COVID-19 on Europe Extracorporeal Membrane Oxygenation Machine Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 4799
Share on
Share on

Europe Extracorporeal Membrane Oxygenation Machine Market Research Report – By Modality, Application & Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends & Forecasts (2019 - 2024)

Pulished: February, 2020
ID: 4799
Pages: 145

Europe Extracorporeal Membrane Oxygenation Machine Market Size & Growth (2019 – 2024):

According to the report, the Europe Extracorporeal Membrane Oxygenation Machine Market Size is valued at USD 67.23 million in 2019 and is expected to reach USD 83.34 billion by 2024, anticipated to grow at a CAGR of 4.39% during the forecast period 2019-2024.

Extracorporeal membrane oxygenation, or ECMO, is a treatment used for patients with life-threatening heart and/or lung problems. It provides long-term breathing and heart support and is used only when all of the standard treatments for those problems have already been tried.

ECMO can support patients for days to weeks while doctors treat their underlying illness. ECMO is performed using a heart-lung bypass machine similar to the one used during open-heart surgery. The ECMO machine often referred to as a “circuit,” is quite large and contains sterile plastic tubing that moves blood from your baby to the “ECMO lung” and then back to your child. The ECMO lung adds oxygen to the blood and removes carbon dioxide, as a healthy lung would.

The growth of the market can be credited to the rise in the number of cases of cardiovascular and respiratory diseases, the increase in the adoption of ECMO as a bridge to lung transplantation, increasing number of ECMO centers, conferences and training programs to increase awareness, and technological advancements. In addition, the increase in the geriatric population and the number of people suffering from diseases in populous countries are factors that are projected to drive the growth of the market.

Moreover, the surge in the adoption of an unhealthy lifestyle and the subsequent development of lifestyle ailments are projected to further expand the COPD incidence rate. Identified risk factors, such as the increase in the tobacco consumption trend in both, males and females, are further supporting the growth of the market. Be that as it may, complications associated with extracorporeal membranes oxygenation machines such as bleeding, infections, and technical failures along with high cost and lack of skilled professionals is a challenge to the market.

Europe Extracorporeal Membrane Oxygenation Machine Market has been segmented and sub-segmented into the following categories

  • By Modality: Veno-Arterial (VA), Veno-Venous (VV), Arterio-Venous (AV).
  • By Application: Respiratory, Cardiac, Extracorporeal Cardiopulmonary Resuscitation (ECPR).
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe.

On the basis of region, Europe accounts for the second-largest share of the market. The favorable reimbursement scenario, rising incidence of lung cancer, and the presence of a large number of ECMO centers are expected to boost the market.

Prominent Companies dominating the Europe Extracorporeal Membrane Oxygenation Machine Market Profiled in the Report are Getinge Group, Medtronic plc, LivaNova PLC, XENIOS AG, Terumo Corporation, MicroPort Scientific Corporation, NIPRO Corporation, OriGen Biomedical Inc., ALung Technologies Inc., and EUROSETS S.r.l.

1.Introduction               

                1.1 Market Definition 

                1.2 Study Deliverables 

                1.3 Base Currency, Base Year and Forecast Periods       

                1.4 General Study Assumptions

2. Research Methodology                        

                2.1 Introduction            

                2.2 Research Phases   

                                2.2.1 Secondary Research                                                           

                                2.2.2 Primary Research                                                 

                                2.2.3 Econometric Modelling                                                      

                                2.2.4 Expert Validation                                                  

                2.3 Analysis Design      

                2.4 Study Timeline       

3. Overview                    

                3.1 Executive Summary

                3.2 Key Inferences      

                3.3 Epidemiology           

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                 

                4.1 Market Drivers       

                4.2 Market Restraints 

                4.3 Key Challenges      

                4.4 Current Opportunities in the Market           

5. Market Segmentation                           

                5.1 Modality   

                                5.1.1 Introduction                                                           

                                5.1.2 Venovenous ECMO                                                             

                                5.1.3 Venoarterial ECMO                                                             

                                5.1.4 Arteriovenous ECMO                                                         

                                5.1.5  Y-o-Y Growth Analysis, By Modality                                                            

                                5.1.6  Market Attractiveness Analysis, By Modality                                                          

                                5.1.7  Market Share Analysis, By Modality                                                            

                5.2 Application

                                5.2.1 Introduction                                                           

                                5.2.2 Respiratory Applications                                                   

                                                5.2.2.1 Neonates                                             

                                                5.2.2.2 Pediatrics                                             

                                                5.2.2.3 Adults                                    

                                5.2.3 Cardiac Applications                                                            

                                                5.2.3.1 Neonates                                             

                                                5.2.3.2 Pediatrics                                             

                                                5.2.3.3 Adults                                    

                                5.2.4 Extracorporeal Cardiopulmonary Resuscitation (ECPR)                                                        

                                                5.2.4.1 Neonates                                             

                                                5.2.4.2 Pediatrics                                             

                                                5.2.4.3 Adults                                    

                                5.2.5 Y-o-Y Growth Analysis, By Application                                                         

                                5.2.6 Market Attractiveness Analysis, By Application                                                       

                                5.2.7 Market Share Analysis, By Application                                                        

6. Geographical Analysis                           

                6.1 Introduction            

                                6.1.1 Regional Trends                                                    

                                6.1.2 Impact Analysis                                                     

                                6.1.3 Y-o-Y Growth Analysis                                                        

                                                6.1.3.1 By Geographical Area                                     

                                                6.1.3.2 By Modality                                         

                                                6.1.3.3 By Application                                    

                                6.1.4  Market Attractiveness Analysis                                                     

                                                6.1.4.1 By Geographical Area                                     

                                                6.1.4.2 By Application                                    

                                                6.1.4.3 By Type                                 

                                6.1.5  Market Share Analysis                                                      

                                                6.1.5.1 By Geographical Area                                     

                                                6.1.5.2 By Modality                                         

                                                6.1.5.3 By Application                                    

                6.2 U.K

                6.3 Spain          

                6.4 Germany  

                6.5 Italy            

                6.6 France       

               6.7 Rest of Europe

7.Strategic Analysis                     

                7.1 PESTLE analysis      

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                       

                7.2 Porter’s Five analysis           

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services                                                              

                                7.2.5 Competitive Rivalry within the Industry                                                     

8.Market Leaders' Analysis                      

                8.1 Getinge Group       

                                8.1.1 Overview                                                 

                                8.1.2 Product Analysis                                                   

                                8.1.3 Financial analysis                                                  

                                8.1.4 Recent Developments                                                       

                                8.1.5 SWOT analysis                                                       

                                8.1.6 Analyst View                                                          

                8.2 Medtronic plc         

                8.3 LivaNova PLC          

                8.4 XENIOS AG

                8.5 Terumo Corporation            

                8.6 MicroPort Scientific Corporation    

                8.7 NIPRO Corporation

                8.8 OriGen Biomedical Inc.       

                8.9 ALung Technologies Inc.    

                8.10 EUROSETS S.r.l.    

9.Competitive Landscape                         

                9.1 Market share analysis         

                9.2 Merger and Acquisition Analysis    

                9.3 Agreements, Collaborations, and Joint Ventures      

                9.4 New Product Launches      

10.Market Outlook and Investment Opportunities                       

Appendix                        

                a) List of Tables

                b) List of Figures           

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Modality and Application along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the Europe Market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensivePESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Extracorporeal Membrane Oxygenation Machine  Market By Modality, From 2019-2024 ( USD Million )
  2. Europe Veno-Arterial (VA) Market By Region, From 2019-2024 ( USD Million )
  3. Europe Veno-Venous (VV) Market By Region, From 2019-2024 ( USD Million )
  4. Europe Arterio-Venous (AV) Market By Region, From 2019-2024 ( USD Million )
  5. Europe Extracorporeal Membrane Oxygenation Machine  Market By Application, From 2019-2024 ( USD Million )
  6. Europe Respiratory Market By Region, From 2019-2024 ( USD Million )
  7. Europe Cardiac Market By Region, From 2019-2024 ( USD Million )
  8. Europe Extracorporeal Cardiopulmonary Resuscitation (ECPR)) Market By Region, From 2019-2024 ( USD Million )
  9. U.K. Extracorporeal Membrane Oxygenation Machine  Market By Modality, From 2019-2024 ( USD Million )
  10. U.K. Extracorporeal Membrane Oxygenation Machine  Market By Application, From 2019-2024 ( USD Million )
  11. Germany Extracorporeal Membrane Oxygenation Machine  Market By Modality, From 2019-2024 ( USD Million )
  12. Germany Extracorporeal Membrane Oxygenation Machine  Market By Application, From 2019-2024 ( USD Million )
  13. France Extracorporeal Membrane Oxygenation Machine  Market By Modality, From 2019-2024 ( USD Million )
  14. France Extracorporeal Membrane Oxygenation Machine  Market By Application, From 2019-2024 ( USD Million )
  15. Italy Extracorporeal Membrane Oxygenation Machine  Market By Modality, From 2019-2024 ( USD Million )
  16. Italy Extracorporeal Membrane Oxygenation Machine  Market By Application, From 2019-2024 ( USD Million )
  17. Spain Extracorporeal Membrane Oxygenation Machine  Market By Modality, From 2019-2024 ( USD Million )
  18. Spain Extracorporeal Membrane Oxygenation Machine  Market By Application, From 2019-2024 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample